• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPharmaceutical Industry

Pharmaceutical Industry

Page 67 of 100
Alnylam’s Stock Is Plummeting After Drug Trial Leads to Patient Deaths
Health
Alnylam’s Stock Is Plummeting After Drug Trial Leads to Patient Deaths
By Sy MukherjeeOctober 6, 2016
Mylan CEO Heather Bresch Testifies On EpiPen Price Increases Before The House Oversight And Government Reform Committee
Health
Government Health Plans Spent Over $1 Billion on Mylan EpiPens Over 5 Years
By Fortune Editors and Reuters and Michelle TohOctober 6, 2016
CIO, 2 Others To Resign After JPMorgan Chase $2 Billion Trading Error
Retail
JPMorgan Is Pulling Chase ATMs from Walgreens Stores
By Reuters and Michelle TohOctober 4, 2016
Herceptin Approved For Treatment Of Scottish Breast Cancer Patients
Health
Samsung’s Biotech Unit Is Seeking Europe Approval for Its Copy of This Drug
By Reuters and Michelle TohOctober 3, 2016
House Oversight Committee Holds Hearing On Rising Price Of EpiPens With Mylan Inc. CEO Heather Bresch
Health
More and More Americans Think Prescription Drug Costs Are ‘Unreasonable’
By Chauncey L. AlcornSeptember 29, 2016
U.S. company stock buybacks are down 21 percent in the first seven months of 2016.
Health
Why Intra-Cellular Therapies’ Stock Got Crushed Today
By Sy MukherjeeSeptember 29, 2016
Shelley Ewalt
Retail
Target Pharmacy Customers Are Not Happy With Their New CVS Pill Bottles
By Madeline FarberSeptember 29, 2016
House Oversight Hearing On Prescription Drug Price Increases
Leadership
Martin Shkreli Is Auctioning Off a Chance to Punch Him in the Face
By Megan McCluskey, TIME and Michelle TohSeptember 28, 2016
This Biotech May Get the First Marijuana-Based Therapy Approved in the U.S.
Health
This Biotech May Get the First Marijuana-Based Therapy Approved in the U.S.
By Sy MukherjeeSeptember 26, 2016
Mylan CEO Heather Bresch Testifies On EpiPen Price Increases Before The House Oversight And Government Reform Committee
Health
3 Highly Dubious Claims Mylan’s CEO Made to Congress
By Sy MukherjeeSeptember 26, 2016
Can a Pill Fix Your Hearing?
Health
Can a Pill Fix Your Hearing?
By Jennifer AlseverSeptember 26, 2016
How a Biotech Turned a Bust Into a Hit
Health
How a Biotech Turned a Bust Into a Hit
By Jennifer AlseverSeptember 26, 2016
How Time Warner’s Former CEO Is Helping Democratize Cancer Research
Leadership
How Time Warner’s Former CEO Is Helping Democratize Cancer Research
By Sy MukherjeeSeptember 23, 2016
Attorney general Loretta Lynch said the department will issue a new plan next week.
Health
35 US States Are Suing This Opioid Maker for Anticompetitive Practices
By ReutersSeptember 23, 2016
Herpes Treatment
Health
This Acne Treatment Now Costs Almost $10,000
By Madeline FarberSeptember 21, 2016
1...
  • 65
  • 66
  • 67
  • 68
  • 69
...100
Most Popular
Big Tech
As Big Tech showers employees with perks to win the talent war, Nvidia built a nearly $5 trillion company by making people pay for their own lunchplaceholder alt text
By Marco Quiroz-GutierrezJuly 1, 2026
Success
Mark Zuckerberg feeds his cows macadamia nuts and beer to create the 'highest-quality beef in the world' on his $300 million estate in Hawaiiplaceholder alt text
By Sasha RogelbergJuly 2, 2026
Personal Finance
Current price of oil as of July 2, 2026placeholder alt text
By Joseph HostetlerJuly 2, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.